DEF 14C: La Rosa Holdings Corp. Secures $468,000 in Funding Through Convertible Note and Warrant Issuance

La Rosa Holdings Corp. announces the issuance of a convertible note, shares, and warrants to an accredited investor for $444,600, with the majority stockholder's approval obtained to comply with Nasdaq listing rules.

Summary

• La Rosa Holdings Corp. entered into a securities purchase agreement on July 16, 2024, with an accredited investor.
• The agreement involves the sale of a $468,000 promissory note, 29,800 shares of common stock, and warrants for 107,900 shares, totaling $444,600.
• The majority stockholder, holding approximately 73.5% of the voting stock, approved the transaction to comply with Nasdaq listing rules.
• The company received net proceeds of $436,100 after deducting fees and expenses.
• The note bears a 13% interest rate and matures on July 16, 2025, secured by the company's assets.
• The note is convertible into common stock at $2.50 per share, subject to adjustments.
• The investor also received warrants to purchase common stock at $3.00 and $2.25 per share.
• A registration rights agreement requires the company to register the shares for resale by August 15, 2024, and have it effective by September 14, 2024.
• The actions will become effective 20 calendar days after the information statement is mailed to stockholders.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While the company secured funding, the terms include potential dilution and restrictions on the use of proceeds.

Positives

• The company secured additional funding of $444,600 to be used for business development and general working capital purposes.
• The majority stockholder's approval streamlines the process and ensures compliance with Nasdaq listing rules.
• The registration rights agreement provides liquidity options for the investor.

Negatives

• The company is issuing shares that could dilute existing shareholders.
• The convertible note could lead to further dilution if converted.
• The company is restricted in how it can use the proceeds from the offering.

Risks

• The conversion of the note and exercise of warrants could significantly dilute existing shareholders.
• Failure to comply with the registration rights agreement could result in penalties.
• The company's ability to meet its debt obligations under the note is crucial.
• The company is limited in its use of the proceeds from the offering.

Future Outlook

The company intends to use the net proceeds from the offering for business development and general working capital purposes.

Management Comments

• The Majority Stockholder consent we have received constitutes the only stockholder approval required under the NRS, Nasdaq Listing Rules 5635(b) and 5635(d), our Articles of Incorporation and our Bylaws, to approve the issuance of the Note, Warrants, and Shares, and all of the Common Stock issuable upon conversion of the Note and exercise of the Warrants.

Industry Context

This type of financing is common for small-cap companies seeking capital, but it often comes with the risk of dilution for existing shareholders. The reliance on a majority stockholder's approval highlights the concentrated ownership structure of the company.

Comparison to Industry Standards

• Similar small-cap companies often use convertible notes and warrants to raise capital.
• The interest rate of 13% is relatively high, reflecting the risk associated with investing in a company like La Rosa Holdings.
• The conversion price of $2.50 per share will be compared to the market price of the stock to determine the attractiveness of the conversion option for the investor.
• The terms of the warrants, including the exercise price and cashless exercise option, are standard in these types of transactions.

Stakeholder Impact

• Shareholders may experience dilution if the note is converted and warrants are exercised.
• The company's employees and business partners may benefit from the increased working capital.
• The investor benefits from the potential upside of the investment and the security of the note.

Next Steps

• The company must file a preliminary information statement on Schedule 14C with the SEC within 10 calendar days of closing.
• The company must file a definitive information statement as soon as permissible.
• The company must file a registration statement registering for resale by the Investor the shares of Common Stock issued or issuable in the Transaction within 30 days of the Closing Date, or August 15, 2024.
• The company must have such registration statement effective within 60 days from the Closing Date, or September 14, 2024.

Key Dates

Keywords

securities purchase agreement, convertible note, warrants, common stock, Nasdaq listing rules, majority stockholder, registration rights, financing